Completed OBSERVATIONAL NCT00283517

A Registry of Treatment Adherence for Patients With Schizophrenia

Electronic Schizophrenia Treatment Adherence Registry, eSTAR

Sponsor: Janssen-Cilag, S.A.

Conditions Psychotic Disorders Schizophrenia

Updated 6 times since 2017 Last updated: Apr 26, 2010 Started: Sep 30, 2003 Completion: May 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00283517, this observational or N/A phase trial focuses on Psychotic Disorders and Schizophrenia and remains completed. Sponsored by Janssen-Cilag, S.A., it has been updated 6 times since 2003, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Janssen-Cilag, S.A.

Data source: Janssen-Cilag, S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.